The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) reported a relatively rare earnings miss in the first quarter on May 2. The biotech announced earnings of $0.48 per share while analysts were expecting $0.50 per share.
http://www.fool.com/investing/general/2013/05/14/should-you-buy-stock-in-gilead-after-the-earnings.aspx
http://www.fool.com/investing/general/2013/05/14/should-you-buy-stock-in-gilead-after-the-earnings.aspx
No comments:
Post a Comment